Girik Pharmaceuticals LLP

Girik Pharmaceuticals LLP - healthcare in Kadubeesanahalli, Karnataka, India. Directors, charges & compliance details.
LLPIN AAI-5098 Incorporated 08 February 2017 ROC Bangalore HQ Kadubeesanahalli, Karnataka, India
Active Limited Liability Partnership healthcare
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
9 yrs
Est. 2017
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Bangalore
ROC office
Incorporated
08 Feb 2017
Date of incorporation

About Girik Pharmaceuticals LLP

Data last updated:

Girik Pharmaceuticals LLP is a limited liability partnership (LLP) based in Kadubeesanahalli, Karnataka, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 08 February 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAI-5098. Its GSTIN is 09AARFG0334J1Z7 (Uttar Pradesh).

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Mithlesh Kumar Bajpai and Akhilesh Kumar Bajpai.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at B – 105 Sv Brindavanam Apartment, Kadubeesanahalli, Karnataka, India – 560103.

Company Details of Girik Pharmaceuticals LLP
LLPIN AAI-5098
Incorporation Date 08 February 2017
Total Obligation of Contribution ₹1 Lakh
ROC Bangalore
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Mithlesh Kumar Bajpai Designated Partner Akhilesh Kumar Bajpai Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    B – 105 Sv Brindavanam Apartment, Kadubeesanahalli, Karnataka, India – 560103
  • Industry
    Healthcare, Alternative & Holistic Medicine
Comprehensive company report
Girik Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Girik Pharmaceuticals LLP report

Financials, compliance, directors, charges, ownership and filings for Girik Pharmaceuticals LLP in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Financials of Girik Pharmaceuticals LLP FY 2025 filings available

Financial Statement Summary of Girik Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Girik Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Girik Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Girik Pharmaceuticals LLP

Girik Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Mithlesh Kumar BajpaiDesignated Partner08 Feb 20179 Years 8 MonthsCurrent
Akhilesh Kumar BajpaiDesignated Partner08 Feb 20179 Years 8 MonthsCurrent
View all designated partners

Charges & Borrowings of Girik Pharmaceuticals LLP

Girik Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Girik Pharmaceuticals LLP

Employment history and EPFO contributions of people linked to Girik Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Girik Pharmaceuticals LLP

Girik Pharmaceuticals LLP has 2 designated partner changes on record since 2017: 2 appointments. The latest: Akhilesh Kumar Bajpai was appointed as Designated Partner on 08 Feb 2017.

AGM
Girik Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Girik Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Akhilesh Kumar Bajpai was appointed as Designated Partner.
Appointed
Mithlesh Kumar Bajpai was appointed as Designated Partner.
Incorporation
08 Feb 2017
Girik Pharmaceuticals Llp was registered on 08 Feb 2017 with Roc Bangalore & aged 9 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Girik Pharmaceuticals LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Girik Pharmaceuticals LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Girik Pharmaceuticals LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Girik Pharmaceuticals LLP

Girik Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AARFG0334J1Z7Uttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Girik Pharmaceuticals LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girik Pharmaceuticals LLP

Girik Pharmaceuticals is an active limited liability partnership based in Kadubeesanahalli, Karnataka, India. The LLP works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 08 February 2017 (9+ years old) and is registered under LLPIN AAI-5098.

Girik Pharmaceuticals has 2 current designated partners:

The GSTIN of Girik Pharmaceuticals is 09AARFG0334J1Z7, registered in Uttar Pradesh.

The LLPIN (Limited Liability Partnership Identification Number) of Girik Pharmaceuticals is AAI-5098. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Girik Pharmaceuticals was incorporated on 08 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.

Akhilesh Kumar Bajpai was appointed as Designated Partner on 08 Feb 2017. Mithlesh Kumar Bajpai was appointed as Designated Partner on 08 Feb 2017.

The registered office of Girik Pharmaceuticals is at B – 105 Sv Brindavanam Apartment, Kadubeesanahalli, Karnataka, India – 560103.

The total obligation of contribution is ₹1 Lakh.

Girik Pharmaceuticals operates in the healthcare industry, in the alternative and holistic medicine segment.

Girik Pharmaceuticals can be reached at its registered office: B – 105 Sv Brindavanam Apartment, Kadubeesanahalli, Karnataka, India – 560103.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available